Pillsbury advised Vue Storefront Inc. on the deal. Vue Storefront Inc. (“Vue”), a global technology startup for ecommerce businesses, in its recent $20 million equity financing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents IDEAYA Biosciences in the offering. IDEAYA Biosciences, Inc. (Nasdaq:IDYA) has announced the pricing of an underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Crandon Law served as counsel to TORL BioTherapeutics, and Latham & Watkins served as counsel to Goldman, Sachs & Co. TORL BioTherapeutics LLC has announced its...
You must be a Standard 1 Year member to access this content.
Cahill represented the initial purchasers in the offering. Adient Global Holdings Ltd, a subsidiary of Adient plc, announced a Rule 144A offering of $500,000,000 aggregate principal...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Coinbase in the transaction. Coinbase announced that it has acquired One River Digital Asset Management (ORDAM). ORDAM will transition to become Coinbase Asset...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop advised TD SYNNEX, Paul Weiss advised the selling stockholders, and Davis Polk advised the lead book-running managers. TD SYNNEX Corporation announced the approximately $502...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP advised Netskope on the deal while Sidley represented Goldman Sachs Asset Management. Latham & Watkins LLP represented Morgan Stanley Tactical Value....
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman advised HYPR Corp. on the deal. HYPR Corp., a New York City-based, venture-backed enterprise security software company, announced a $25 million series C1...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP, Gowling WLG and Perkins Coie advised Blockchain Coinvestors Acquisition Corp. I on the deal. Blockchain Coinvestors Acquisition Corp. I (BCSA), a...
You must be a Standard 1 Year member to access this content.
